List of works - Michel Meignan

<sup>18</sup>F-FDG PET maximum intensity projections and artificial intelligence: a win-win combination to easily measure prognostic biomarkers in DLBCL patients

scientific article published in 2022

A tumor volume and performance status model to predict outcome prior to treatment in diffuse large B-cell lymphoma

scientific article published in 2022

An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.

scientific article published on 7 May 2013

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.

scientific article published on 22 August 2016

FDG-PET in PMBCL: which heterogeneity?

scientific article published on 01 July 2018

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

scientific article published on 01 April 2020

Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and G

scientific article published on 29 October 2012

PET-guided clinical trials in Hodgkin lymphoma: to agree or not to agree, that is the reviewer's question

scientific article published on 12 October 2017

Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma

scientific article published on 6 June 2014

Prognostic model for high tumor burden follicular lymphoma integrating baseline and end induction PET: a LYSA/FIL study.

scientific article published on 20 March 2018

Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project

scientific article published on 01 August 2019

Quantitative FDG-PET: a new biomarker in PMBCL.

scientific article

Reply to H.J.A. Adams et al and E. Laffon et al

scientific article published on 28 December 2016

Reply to J. Wang et al

scientific article published on 12 February 2019

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report

scientific article published in March 2017

SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma

scientific article published on 25 April 2011

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale